Fresh analysis suggests that individuals who come off popular slimming jabs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who end conventional lifestyle regimens.
Published data in a prominent health publication shows that while obese individuals often shed substantial amounts of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing such medications need to be cognizant of the danger of fast rebound weight gain when the treatment ends," warns lead investigator Dr. Susan Jebb.
That rate of recovery means a return to original mass in about 18 months.
Comparing Treatments
The study, which reviewed 37 of studies involving over 9,000 of patients, compared the outcomes of the injectable medications with other pills.
The team point out that people who shed pounds through diet and exercise typically see a more gradual creep back—approximately 0.1 kg a month—after stopping.
Explaining the Fast Rebound
Doctors believe the way of the drugs explains the amplified weight return.
These medications imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than normal might result in the body to produce less of its endogenous GLP-1, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement leads to hunger is no longer kept in check, making excessive eating far more likely."
A Chronic Condition?
Medical guidelines suggest the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Many experts argue that, due to the high risk of relapse, the therapy might need to be ongoing.
This view is echoed by drug manufacturers, who note that the results "highlight the persistent character of obesity," comparing it to managing conditions like diabetes.
User Experiences
Users who have come off the medication explain a intense resurgence of cravings.
"It was like a switch that goes on and you become extremely hungry," recalled an individual.
This challenge is compounded if individuals have not established lasting lifestyle or habit changes during therapy.
Widespread Interest
Figures suggest that a significant number of people in the UK have used these injections in the last 12 months, with interest continuing to grow.
- Use is higher among women than males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are effective tools for weight loss, they are not a standalone fix and long-term success likely depends on ongoing lifestyle changes.
